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Abstract
Background: Plasmodium vivax is the most widespread malaria parasite. It has a dormant stage in the human liver,
which makes it difficult to eradicate. It is proposed that a relapse of vivax malaria, besides being genetically
determined by the specific strain, is induced by the bites of uninfected vectors.
Presentation of the hypothesis: The dormant stage maximizes the possibility for the parasite to reach the vector
for sexual reproduction. The advantage would increase if the parasite was able to detect the presence of a new
generation of vectors. The sporozoites function both in the vector and in the human hosts. They invade the cells
of the salivary gland in the vector and the hepatocytes in the human. Some of the sporozoites develop into
hypnozoites in the human liver. It is suggested that the hypnozoite activates when it recognizes the same
Anopheles specific protein, which it had previously recognized as a sporozoite to invade the salivary gland in the
vector. Another possibility is that the hypnozoite activates upon the bodily reaction by the human on a bite by an
Anopheles female.
Testing the hypothesis: The connection between the relapse and a new generation of vectors can be
documented by simultaneous monitoring of both parasitaemia in humans and the presence of uninfective/
infective vectors in the same area with seasonal malaria transmission. Experimental studies are needed to find the
saliva components, which trigger the relapse. Although P. cynomolgi in monkeys also has hypnozoites and relapses,
testing with monkeys might be problematical. These live in a reasonably stable tropical environment where
relapses cannot easily be linked to vectors. The importance of the trigger increases in unpredictable variations in
the vector season.
Implications of the hypothesis: Artificial triggering of hypnozoites would make the medication more effective
and resistance against a protein that the parasite itself uses during its life cycle would not develop. In areas with
seasonal vivax malaria it could be used locally for eradication.
Background
Plasmodium vivax is the most common human malaria
species outside Africa with 2.6 billion people at risk in
South Asia, Southeast Asia, South and Central America
[1]. It is the most widespread malaria parasite and was,
until the middle of the 20th century present in almost
the whole inhabited world with presumably the exception
of West and Central Africa [2]. Plasmodium vivax has a
dormant stage in the human liver. After the sporozoites
enter the hepatocytes not all will develop into schizonts,
but some remains as hypnozoites [3]. The hypnozoites
can remain dormant for months, or even years and the
mechanism behind the development into dormancy and
the activation is not known. The hypnozoites are insensi-
tive to atovaquone-proguanil, which is active against liver
stage schizonts and to chloroquine [4]. Relapses indicat-
ing a dormant stage occur also in Plasmodium ovale and
in the simian Plasmodium cynomolgi, Plasmodium fieldi,
Plasmodium simiovale and Plasmodium schwetzi infec-
tions [5-7]. A dormant stage in P. ovale has recently been
questioned [8]. Plasmodium falciparum and Plasmodium
malariae do not have a dormant liver stage. Instead, the
gametocytes of P. falciparum can survive in the blood
for months [9] and P. malariae can cause long time
chronic infections, which reoccur decades after the initial
exposure [10].
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strains of P. vivax.I ti so n l y1 7d a y si nt h eC h e s s o n
strain from New Guinea [4], but in the eastern parts of
Finland relapses could be statistically detected at least
nine years after the primary infection [11]. The strain
from Eastern Finland is now extinct, but it was probably
close to the hibernans strain. The latter was isolated
from north of Moscow [12]. A long dormancy is also
known from tropical areas. A length of four years in a
patient from Cameroon has been reported in Italy [13].
The proportion of how many hypnozoites are produced
from the sporozoites injected with one vector bite is
unknown. It has been suggested that more hypnozoites
are produced when the infected mosquitoes are housed
at a cold temperature [14]. The variation in the dormancy
period of the hypnozoites is a polymorphic character in
P. vivax, and the variation in the relapse time can be
explained as a result of regional and seasonal variation in
the mosquito vector. Unpredictable seasonality or unpre-
dictable vector populations will select for a character that
produces hypnozoites with a long dormancy. It is unlikely
that a fixed length of dormancy alone would have
ensured the survival of P. vivax through evolutionary
time scales. It is probable that the parasite also has some
means of finding the vector. Ability for the hypnozoites
to detect the presence of a new generation of vectors
would explain the geographical success of P. vivax.
Colder regions in the temperate zone correlate with
the increase of long dormancy period of vivax malaria.
A long dormancy in the tropics is less pronounced
because the relapse is easily hidden by continuous
presence of mosquitoes.
A relapse of vivax malaria, besides being genetically
determined by the specific strain, could also be induced
by the bites of uninfected vectors. This was statistically
indicated in the long time dataset from Finland [11].
The Finnish domestic vector, Anopheles messeae,h a sa
strong seasonality. The females hibernate as adults
through winter and lay eggs in the spring. The develop-
ment of the larvae takes place in summer in permanent
water, which freezes during the winter. Monitoring of
mosquitoes with the commercial MosquitoMagnet has
been done by the authors from May to October 2008-
2010 both in the South and in the North of Finland. No
adult Anopheles females were flying between the begin-
ning/middle of June and late July/August. Anopheles
were also absent in a study of mosquitoes attracted to
man in Finland in the middle of summer [15]. When
the next generation of adult hatches in late July/August,
it is already too cold for the sporogony. The late sum-
mer/early autumn malaria top in the Finnish material
had, therefore, to be relapses and they showed a distinct
connection with the vector phenology [11].
The same pattern can be found from British material.
Analyses of domestic relapses of imported P. vivax cases
showed an adaption to the phenology of local vectors.
On return to the UK, clinical malaria tended to develop
in patients returning to Birmingham from Northern
Pakistan during the summer months irrespective when
the patients had got the original infection [16]. It was
suggested that the cold winter months somehow “pro-
grammed” the parasites to correlate with the appearance
of the biting mosquitoes. A comparison with the phe-
nology from Finland shows, however, that this is not the
case. There the number of malaria cases went down
during the warm summer months, when the vectors
only were present as larvae. A parsimonious explanation
for both the Finnish and the British material is that the
hypnozoites react on the local phenology of the vectors.
Other British studies show the same adaptation to
local seasonality. A study made in Glasgow showed that
the onset of imported vivax malaria became confined to
and delayed to the British summer months irrespective
of when the infection was contracted [17]. A similar lar-
ger study was done in London. The majority of the
patients had got the infection in Punjab, India and some
cases had been contracted in Africa and the Middle
East. There was a great variation in the incubation peri-
ods and clinical attacks of malaria were almost absent
during the winter months [18].
Unfortunately there is no monitoring of the presence
of Anopheles females indoor in British suburban areas.
A study made in Helsinki during the malaria epidemic
1901-1902 showed that active Anopheles females could
easily be found in apartments in the middle of the city
[19,20]. Anopheles messeae was abundant in the mos-
quito material collected by the authors with a trap at
the university campus in Helsinki 2008-2009.
A case that describes simultaneous occurrence of
relapses in two persons living together has also been
described from Canada, where a volunteer couple had
got infected with both P. falciparum and P. vivax in
Papua New Guinea. After a holiday at Lake Winnipeg in
August both the husband and the wife got a relapse
within one week apart. The authors suggested that the
hypnozoites were programmed genetically to be activated
at defined intervals or that they reacted on outside sti-
muli as cold or stress [21]. It should be noted that also in
this case the relapses occurred during the local Anopheles
season.
Hypnozoites triggered by uninfected mosquitoes?
T h eb i o l o g yb e h i n dt h ed o r m a n c yi su n k n o w n .T h e
investment of some of the sporozoites into hypnozoites
gives the parasite several advantages. It will maximize the
possibility for the parasite to reach the vector for sexual
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more than one occasion. A strain-dependant minimum
time during which the hypnozoite remains inactive
before it can be activated may also be assumed.
The advantage increases considerable if the activation
of the hypnozoites does not happen at random or is
only genetically “programmed”, but are triggered by the
parasite. Activation during the vector-free season would
be disastrous in areas with seasonal vectors. Instead, it
is proposed that the relapsesa r et r i g g e r e db yt h eb i t e s
of uninfected vectors. In the long time series from
Finland, relapses are shown to coincide with the season-
ality of the main vector [11]. The adult mosquitoes
hatch during the end of the summer, and after mating
the males die and the females seek a hibernation place.
During this time there were no infective mosquitoes
present but the number of malaria cases increased.
Blood feeding is not a prerequisite, but 15% of the
females still take blood before hibernation [22].
Plasmodium vivax has probably evolved in Southeast
Asia between 217,000 and 304,000 years ago when
humans lived in small nomadic groups [23]. A human
host brought new challenges for the parasite. The
humans had bigger territories than the tree living mon-
keys. For P. vivax, it was necessary to have access to both
the human and the vector. The human group would not
necessarily always stay at a place long enough for the
sporogony to be completed. The groups were small,
which affected the number of people that an infective
vector could bite. Even though the seasonality of the vec-
t o ri sl e s sp r o n o u n c e di nt h et r o p i c st h a ni nN o r t h e r n
areas, there still is a difference between the dry and rainy
season. Vivax malaria was probably a rare disease in the
Palaeolithic society with hunters and gatherers. The
dormant stage with an ability to recognize the new gen-
eration of vectors would have insured the survival of the
parasite during periods without vectors. Triggered
relapses would efficiently infect the vectors and insure
the transmission to new human hosts.
The development of agriculture brought human in a
much closer contact with the Anopheles mosquitoes than
before. Larvae of Anopheles a r em o s t l yf o u n di nw a t e r
bodies like permanent and semi-permanent pools, rice
fields, margins of lakes and rivers with reduced water
flow, and puddles or ditches with a growth of aquatic
vegetation [24]. Only when humans built permanent set-
tlements near the optimal breeding places, malaria
started to be an essential health problem.
The Finnish malaria data showed a correlation between
the newly hatched, uninfective Anopheles females and the
late summer/early autumn top of malaria cases. The ear-
lier phenology of the other man-biting species did not
correlate with malaria cases [11]. An ability to recognize
the presence of a suitable vector would also make the
dispersal of P. vivax very effective. This was indicated
during the gold rush in Klondyke. Thousands of prospec-
tors rushed to Dawson city in 1897 and 1898 where they
suffered severely from malaria [25]. Several of the newco-
mers carried hypnozoites and the parasite adapted easily
to the local common vector species, Anopheles earlei
[26]. Malaria ceased to be a problem with no relapses
when the prospectors moved from Klondyke further
westwards to Nome on the tundra in Alaska, where there
were no local Anopheles species present.
The Anopheles-bite triggered relapse would, beside to
ensure the survival of the parasite through a vector free
season, allow effective dispersal to new areas and provide
better possibilities for the parasite to reach a vector. The
control of the activation of the hypnozoites might also
increase the possibility for P. vivax to have meiotic
recombination in the mosquitoes. A human could then
have several primary infections without relapses. With
every new infection some of the sporozoites would
remain as hypnozoites in the liver. When the hypnozoites
are activated by the bites of uninfected vectors there
would be a synchronous development of hypnozoites
from different strains [27]. The mechanism would
explain the considerable genetic diversity in P. vivax,
which has been emphasized in several studies [28]. It has
also been showed that the genotypes of the P. vivax
population are often different from the parasite that
caused the primary infection [29]. A simultaneous relapse
of hypnozoites from different infections would also
explain the genetically different parasites present in mul-
tiple infections that have been shown in studies from
India [30,31].
T h es u c c e s so fm a l a r i at r a n s m i s s i o nd e p e n d so nt h e
sporozoites, which can function in both the vector and
the human host. They develop in the oocysts and are
released into the haemocoelic cavity. The sporozoites are
then transported by the circulation [32] of the haemo-
lymph or they follow the continuum of the basal lamina
of the midgut until they come to the surface of the sali-
vary gland [33]. Only 19% of the sporozoites will reach
the salivary gland [34]. The sporozoite invades only the
salivary gland, not any of all the other cells and tissues of
the mosquito, which means that they are able to differ-
entiate between them. The invasion of the salivary gland
probably requires species-specific receptor-ligand inter-
actions [32,35]. The trans-membrane surface protein
TRAP (thrombospondin-related anonymous protein)
mediates cell invasion of the sporozoite and has an
important role for the locomotion. Another transmem-
brane protein of the sporozoite, an apical membrane
antigen/erythrocyte binding-like protein (MAEBL) med-
iates salivary gland recognition and adhesion [36].
T h es p o r o z o i t ei n v a s i o no fP. falciparum into the sali-
vary glands of Anopheles gambiae and Anopheles stephensi
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acid peptide SM1 binds tightly to the salivary gland and
inhibits the sporozoite invasion and Anopheles salivary
protein saglin is a receptor for SM1 [37]. The peptide is a
mimotope of the sporozoite TRAP and saglin/TRAP inter-
action seems to be important for the salivary gland inva-
sion [37]. The infective vector then injects the sporozoite
into the human host. The behaviour of the sporozoites
changes depending on where they are and the migratory
activity was increased in non-hepatic cells compared to
hepatocytes [38].
The biological determinant of the sporozoites to
develop into either active schizonts or dormant hypno-
zoites is unknown [3]. The simplest hypothesis would be
that not all sporozoites enter the hepatocytes at the same
time. It has been assumed that the sporozoites usually
leave the injection site within minutes of the bite. Experi-
ments with mice have showed that the sporozoites can
remain infective for a long period in the mammalian host
and that some sporozoites begin to develop in the drain-
ing lymph node [38]. Perhaps the development of schi-
zonts in the hepatocytes also deters the development of
other sporozoites. The late-comers will instead survive as
dormant hypnozoites. The ability for a Plasmodium to
react on the vicinity of another parasite is known, but not
in the liver stages. The merozoites of P. falciparum avoid
penetrating cells, which are already occupied [39].
When the hypnozoite lies dormant in the human hepa-
tocyte it has already during its life cycle recognized the
mosquito salivary gland. The vector injects saliva into the
host during feeding. The hypnozoite could react with a
protein in the vector saliva, which is specific for the
Anopheles genus. Saglin could be one of the candidates.
Another possibility is that the hypnozoite activates upon
t h eb o d i l yr e a c t i o nb yt h eh u m a no nab i t eb ya nAno-
pheles female. A study with sera from malaria patients,
healthy villagers and people from non-malarious regions
in Thailand showed that the malaria patients reacted
against mosquito antigens. They had anti-Anopheles sali-
vary protein antibodies that were Anopheles-specific.
There were also indications that the antibodies were spe-
cific for the Anopheles species [40]. Possibly both a
human reaction and the protein from the vector saliva
are needed. More research is needed because experi-
ments with intravenous injections of sporozoites of
P. cynomolgi dissected from salivary glands to monkeys
also resulted in relapses [5].
Testing the hypothesis
The analysis of the Finnish material was based on histori-
cal data without the use of quinine or Peruvian bark.
Although it was statistically tested, it should be compared
with modern material in which the malaria cases are diag-
nosed by blood smear. The British material should also be
reanalysed and compared with the local vector distribution
and phenology. The problem with the analyses of
i m p o r t e dc a s e si s ,h o w e v e r ,t h ep o s s i b l ed e p e n d e n c yo n
the original vector. The triggered relapse might be caused
by a combination of several components in the saliva and
a species dependent human reaction against the bite. It is
also possible that the hypnozoites will only be activated if
the human carrier has antibodies to the potential vector
species. If a human carrier moves to an area with different
vector species, the hypnozoites would in that case only
react after one mosquito season when the carrier has
acquired antibodies against the possible new vector.
More statistics of malaria cases and data from vector
monitoring should be collected. A thorough follow-up of
vivax malaria cases together with vector monitoring in an
area with seasonal malaria transmission should, therefore,
be done. The infectivity of the potential vectors should be
determined and their timing compared to the malaria
cases. The connection between the relapse and a new gen-
eration of vectors can be documented by simultaneous
monitoring of both parasitaemia in humans and the pre-
sence of uninfective/infective vectors in the same area.
Experimental studies are needed to find the recognizable
saliva components, which triggers the relapse. Testing
with P. cynomolgi on monkeys might be problematical. It
infects rhesus macaques in Southeast Asia and is closely
related to P. vivax [41]. The clinical infection of both para-
sites is very similar. P. cynomolgi also has the dormant
liver stage with hypnozoites that causes the relapsing
blood stage infection [40]. The evolution of P. cynomolgi is
closely related to monkeys, which are highly tropical ani-
mals and live in a reasonably stable environment. Their
territory is relatively small and the vector will usually find
its primate host. The vector would, therefore, from the
parasite’s point of view, always be easy to find. The
circumstances for P. vivax are almost the opposite. It has
been worldwide successful because it has been able to
adapt to an environment with a highly irregular presence
of vectors.
Implications of the hypothesis
The determination of a component in the vector saliva,
which induces or triggers the relapse of vivax malaria,
would change the medication, since it is easier to treat
the parasite in the bloodstream than the hypnozoites in
the liver. Primaquine resistance has already appeared and
will be more common in the future. Resistance against a
protein that the parasite itself uses for activation could
not develop. If the hypnozoites could be artificially acti-
vated the possibilities for efficient medication would
increase. Drug resistance, which is a growing problem, is
a result of a parasite adapting to a change in its environ-
ment. It will, however develop slower with controlled
relapses, simply because the number of inadequately
Hulden and Hulden Malaria Journal 2011, 10:90
http://www.malariajournal.com/content/10/1/90
Page 4 of 6treated relapses originating from one infection would
decrease.
Activation of the hypnozoites is the key for the survi-
val of P. vivax in areas with seasonal vectors. It could,
however, also be used as a way of effective vivax eradi-
cation on a regional scale. By activating the hypnozoites
out of mosquito season and treating the patients, the
number of infective vectors would be reduced during
the next malaria season; in combination with vector
control indoors and bed nets, eradication could be
achieved faster than only with traditional means.
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